Found 44 matching trials
Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. PHASE2 The study is designed to investigate the safety, tolerability and efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) PHASE2 This is a Phase II, open-label multicentre, randomised study to assess the ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Autologous Fibrin Glues for Fistulas Closure PHASE1 Adjuvant use of fibrin glue in the fistula tract may promote healing in low...
Show More Location
Department of Surgery, Jinling Hospital
Learn More & Join Trial
Treatment of Orthostatic Intolerance PHASE1 This trial is designed to study the effects of various mechanistically uniq...
Show More Status
Active Not Recruiting
Location
Vanderbilt University Autonomic Dysfunction Center
Learn More & Join Trial
Open Label Study of Octreotide Implant in Patients With Acromegaly PHASE2 To evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) response of a...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia PHASE1 Somatostatin analogues are a last resort for medical intervention in hyperi...
Show More Location
University of Colorado Denver
Learn More & Join Trial
GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma PHASE2 The hepatocellular carcinoma (HCC) represents more than 5% of all human mal...
Show More Location
D. Cotugno Hospital
Learn More & Join Trial
Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly PHASE1 The objectives of the protocol is to determine the maximum tolerated dose a...
Show More Location
Antwerp University Hospital
Learn More & Join Trial
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) NA The purpose of this study is to investigate over a 6 month period the effec...
Show More Location
Duke University Medical Center
Learn More & Join Trial
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly PHASE3 The purpose of this trial is to assess the long-term safety and efficacy of...
Show More Location
UCLA Department of Medicine Division of Endocrinology
Learn More & Join Trial